DeepWave Technologies and Eterly form Strategic Partnership to Bring Personalized Wellness to the Public

DW ET.png

Thursday, Feburary 1, 2018, Vancouver, Canada:

After both companies presented at the Precision Medicine World Conference (PMWC) in San Francisco last week, the data-science driven neurotechnology company DeepWave Technologies and longevity-focused health and fitness mobile app Eterly have cemented their burgeoning relationship through the formation of a strategic partnership to synergistically enhance their growth, capabilities and services, while enhancing the joint marketing strategy and dynamic of client acquisition for both companies.

Eterly will enhance Deep Wave’s research and development facility by integrating the company’s services with their mobile app and substantial software development resources, as well as additional AI-driven machine learning predictive analytics techniques, helping Deep Wave to optimize its analysis of sleep patterns, and finetune its front-facing offering.

In turn, Deep Wave will empower Eterly’s app and platform with its advanced expertise in SleepTech, which is at the forefront of longevity and personalized health research in the neurotech sector, augmenting Eterly’s own daily monitoring of users’ sleep patterns, resulting in more and better personalised recommendations.

As part of the agreement, Deep Wave will join Eterly’s open marketplace for health, fitness and longevity treatments and products as a trusted vendor.

At PMWC, both companies delivered presentations alongside many other companies, including IBM Health, 23andMe, Calico Labs, Elysium, Stanford Healthcare, and Harvard University. Eterly presented as part of the Aging and Wellness track, and Deep Wave within the Big Data & AI in Precision Medicine track, raising significant interest from attendees.

Among interest from several interested potential partners, Eterly and Deep Wave decided to establish this strategic partnership, recognising the significant synergies between the two companies, notably in terms of research and development, breakthrough technology, data sharing and a shared client base.

DeepWave is working towards correlating the effect of interventions, diet and lifestyle choices and other scientifically relevant data with their nightly sleep EEG data so as to track the effect of lifestyle changes and medical interventions on the quality of sleep. Rather than developing an app internally, the decision was taken to cooperate with an exclusive partner, Eterly, that has already built the back-end and front-end infrastructure they require for these purposes.

Meanwhile, Eterly users will have access to certain premium features offered by DeepWave, and will be able use the Eterly app to track their sleep quality and interface with their DeepWave wearable. DeepWave and Eterly have also agreed to conduct joint marketing campaigns to leverage the public awareness and mounting enthusiasm surrounding each company.

Andrew Ahachinsky, CEO and founder of Eterly, commented that “Sleep is one of the most important aspects of overall health and many people simply aren’t getting enough, whether quality or quantity. That is why we are excited to be partnering with Deep Wave. We are looking forward to adopting their unique and ground-breaking approach to sleep pattern analysis, and sharing the positive benefits; improved memory, focus, and better health; with users of our app and our platform.”

“DeepWave is excited to be partnering with Eterly on the matter of software development and R&D activities. Eterly is filling a vacant need that the public has a strong desire for – namely, a longevity-focused mobile app backed by science and enhanced via AI, and DeepWave is equally happy to be providing Eterly with expert counsel in terms of sleep health and sleep science. Given the deep ties that deep sleep has to longevity and age-related cognitive decline, we feel that we will bringing significant contributions to the sleep recommendations given by Eterly’s app, and hope that this partnership leads to synergistic enhancement of both of our companies’ activities in the years to come” said Giovanni Santostasi, Chief Science Officer of DeepWave Technologies.

About the companies

Eterly is an Artificial Intelligence app designed to reinforce habits for a healthier, and longer life. Combining  proprietary technology, the latest medical research, and machine learning predictive analytics capabilities, accessed via a blockchain back end system, Eterly has been custom built to act like a personal coach, designing and adjusting, in real time, a health and fitness routine mapped to precisely fit every user’s specific needs. The Eterly app dovetails seamlessly with users’ fitness tracker wearable devices, collecting, storing and processing data to make smart, proactive recommendations to maximise the benefit of users everyday healthy lifestyle choices, in an intuitive and interactive way.

Deep Wave Technologies is a neurotechnology start-up funded via government grants and a cooperative agreement with DARPA, focused on enhancing memory and cognition through the process of Slow Wave Sleep (SWS), or “deep sleep” using technology developed by Dr. Giovanni Santostasi and his colleagues. The device uses an EEG system that synchronizes with the user's own brainwaves and employs precisely-timed pulses of a pink noise to increase the amplitude of SWA using sound alone. The proprietary algorithm has been tested on individuals using laboratory-grade EEGs; results showed a 300% increase in the memory-strengthening effects of a natural night of sleep versus a night of natural sleep alone. Research has shown that sounder sleep can significantly reduce the risk of stroke, depression, heart attack, hypertension, obesity and diabetes.

DeepWave Technologies Presents at Precision Medicine World Conference 2018

giovanni pmwc.jpeg

Thursday, February 1, 2018, San Diego, California: Deep Wave Technologies Chief Science Officer Giovanni Santostasi, PhD, gave a presentation on the latest developments underway at Deep Wave Technologies laboratories at the Precision Medicine World Conference on January 23, 2018.

Deep Wave Technologies is an neurotechnology start-up funded via government grants and a cooperative agreement with DARPA, focused on enhancing memory and cognition by enhancing the process of Slow Wave Sleep (SWS), or “deep sleep.” It’s underlying technology has been covered in top scientific journals along with high-profile media including Time Magazine, The Wallstreet Journal, Smithsonian Magazine, Daily Mail, International Business Times, CBC, CBS, FOX News, The Huffington Post, Daily Mail, Metro, Express, Medical News Today, and many more. DeepWave’s core technology has been the subject of several published scientific papers on the company’s core technology in numerous peer-reviewed scientific journals, including Neuron, Frontiers in Human Neuroscience, Journal of Neuroscience Methods, Sleep and Sleep Medicine.

The state of sleep known as Slow Wave Sleep is driven by specific types of brain waves called Slow Waves (SW). Its main function is memory consolidation (transfer of memory from short term to long term storage, and individuals who learn a task and perform a memory test immediately before sleep and immediately upon waking score higher in the morning due to the memory-strengthening effect of SWS. The device uses an EEG system that synchronizes with the user's own brainwaves and uses precisely-timed pulses of a pink noise to increase the amplitude of SWA using sound alone. Dr. Giovanni Santostasi and his colleagues have tested this proprietary algorithm on individuals using laboratory-grade EEGs, showing a 300% increase in the memory-strengthening effects of a natural night of sleep (i.e. demonstrating an increase % increase in memory test scores 4x the % increase in memory test scores due to natural sleep alone)

His presentation focused on the vast implications that Slow Wave Sleep has on memory, learning, cognition, and cardiometabolic health, and went on to describe the newest developments occurring at DeepWave Technologies, including ongoing prototype development and planned future R&D activities.

“DeepWave was pleased to present at the Precision Medicine World Conference 2018 alongside such companies as Calico, 23andMe, IBM Health, Elysium, Microsoft, HP, Stanford Healthcare and many more. I presented on the latest developments underway at DeepWave Technologies, including ongoing prototype development and our newest R&D activities. The conference was an excellent opportunity to network with potential partners and investors, and participants came away with a much-expanded view on the exciting developments and convergences occuring in the field of precision medicine” said Giovanni Santostasi, PhD, Chief Scientific Officer of DeepWave Technologies.

DeepWave was one of the most well-received presenters in their track (AI and DataScience Showcase), in particular because it was the only presenter focusing on the application of AI and precision medicine for SleepTech, an emerging sector within the broader neurotechnology industry, and one that holds great promise to become one of the largest sectors within the industry due to the deep ties between sleep and many aspects of health and wellness, including cardiometabolic health, cognitive performance, mood, memory, and aging.

DeepWave made several valuable connections and formed strategic partnerships while at PMWC 2018. Notable among them is their partnership with Eterly, a precision health mobile app empowered by machine learning and focused on healthy longevity, involving integrated customer offerings, joint software and mobile app development and coordination of joint R&D activities, as well as the Comite Center for Precision Medicine, one of the leading precision and preventive medicine clinics in New York employing cutting edge SleepTech, involving the use of DeepWave’s commercial device at Comite clinics.

About DeepWave Technologies

DeepWave Technologies developed through years of neuroscience research by top scientists in the field. These technologies form the core of a non-pharmacological, non-invasive approach to enhancing slow-wave sleep (SWS) and its therapeutic benefits. By improving sleep quality, DeepWave's solution dramatically boosts memory and learning, increases focus and reduces stress. Research also shows that sounder sleep can significantly reduce the risk for stroke, depression, heart attack, hypertension, obesity and diabetes. Basically, when you sleep better, you think smarter and live healthier.

The Sleep Cure: The Fountain of Youth May Be Closer Than You Ever Thought

Mark Zielinski knew he was onto something when his mice stopped sleeping. Normally, the animals woke and slept on a 12-hour cycle. When the lights were on in the lab, the mice were active. When it went dark on a timer, down they went. But Zielinski, who teaches psychiatry at Harvard Medical School, had recently tweaked their schedule to keep the mice up past their bedtime.

Zielinski and his colleagues would rustle the bedding in the mice's cages to keep them from dozing off when they started to display the telltale signs of sleepiness--drooping lids, sluggish walk, EEG readings showing their brain activity was waning. But Zielinski noticed that when the mice were left alone to slumber at will after the disruption, they didn't, or perhaps couldn't, fall asleep. 

Continue reading on


Russell Foster: Why do we sleep?

Russell Foster is a circadian neuroscientist: He studies the sleep cycles of the brain. And he asks: What do we know about sleep? Not a lot, it turns out, for something we do with one-third of our lives. In this talk, Foster shares three popular theories about why we sleep, busts some myths about how much sleep we need at different ages — and hints at some bold new uses of sleep as a predictor of mental health.